Synopsis
Synopsis
0
CEP/COS
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Listed Dossiers
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. (s)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide
2. 2-(4-(3-fluorobenzyloxy)benzylamino)propionamide
3. Fbap Methanesulfonate
4. Fce 26743
5. Fce 28073
6. Fce-26743
7. Fce-28073
8. Nw-1015
9. Pnu 151774e
10. Pnu-151774e
11. Safinamide
12. Safinamide Methanesulfonate
13. Xadago
1. 202825-46-5
2. Safinamide Mesilate
3. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide Methanesulfonate
4. Pnu-151774e
5. Nw-1015
6. Safinamide (mesylate)
7. Safinamide Methanesulfonate
8. Pnu 151774e
9. Safinamide Mesylate [usan]
10. Fce-28073
11. Nw 1015
12. Safinamide Methansulfonate
13. Ys90v3dtx0
14. Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2s)-, Methanesulfonate (1:1)
15. 202825-46-5 (mesylate)
16. Safinamide Mesilate (jan)
17. Safinamide Mesylate (usan)
18. Safinamide Mesilate [jan]
19. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)-amino)propanamide Methanesulfonate
20. Chembl48582
21. (s)-2-[[4-[(3-fluorobenzyl)oxy]benzyl]amino]propanamide Methanesulfonate
22. Unii-ys90v3dtx0
23. Fce-28073(r-isomer)
24. Safinamidemesylate
25. Equfina (tn)
26. Xadago (tn)
27. Safinamide Mesylate Salt
28. Emd 1195686 Mesylate
29. Mls006010740
30. Schembl1665715
31. Dtxsid80942414
32. Hms3884o17
33. Safinamide Mesylate (fce28073)
34. Amy38833
35. Bcp16018
36. Ex-a2640
37. Hy-70057a
38. Mfcd15145475
39. S1472
40. Safinamide Mesilate [who-dd]
41. Akos015902297
42. Ccg-268636
43. Safinamide Methanesulfonate [mi]
44. Safinamide Mesylate [orange Book]
45. Ac-27739
46. As-75602
47. Pnu-151774e,fce28073
48. Smr004701699
49. Safinamide Mesylate Salt, >=98% (hplc)
50. Cs-0006742
51. Sw219452-1
52. D10191
53. J-013174
54. Q27294690
55. (s)-2[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate
56. (s)-(+)-2-(4-(3-fluorobenzyloxy) Benzylamino)propanamide, Methanesulfonate
57. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamidemethanesulfonate
58. (s)-2-[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate
59. (2s)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic Acid
60. Propanamide, 2-(((4-((3-fluorophenyl)methoxy)phenyl)methyl)amino)-, (s)-, Monomethanesulfonate
| Molecular Weight | 398.5 g/mol |
|---|---|
| Molecular Formula | C18H23FN2O5S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 398.13117117 g/mol |
| Monoisotopic Mass | 398.13117117 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 438 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Xadago is indicated for the treatment of adult patients with idiopathic Parkinsons disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.
N04B
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34164
Submission : 2019-09-30
Status : Active
Type : II
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2025-07-25
Registration Number : Su579-4-ND
Manufacturer Name : Zakłady Farmaceutyczne Polpharma SA
Manufacturer Address : 19 Pelplińska Str., 83-200 Starogard Gdański, Poland
| Available Reg Filing : ASMF |
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-11-05
Pay. Date : 2020-09-28
DMF Number : 35201
Submission : 2020-09-28
Status : Active
Type : II
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-0511
Address of the Firm :
NDC Package Code : 73435-012
Start Marketing Date : 2020-12-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Registrant Name : Hoosung Bio Co., Ltd.
Registration Date : 2025-05-09
Registration Number : Su21-31-ND(1)
Manufacturer Name : Honour Lab Limited Unit-IX
Manufacturer Address : Survey No. 332, 335, 336 & 341, Veliminedu Village, Chityal Mandal, Nalgonda District-508114, Telangana State, India
| Available Reg Filing : ASMF |
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2025-04-04
Registration Number : Wed 21-31-ND
Manufacturer Name : Honour Lab Limited Unit-IX
Manufacturer Address : Survey No. 332, 335, 336 & 341, Veliminedu Village, Chityal Mandal, Nalgonda District-508114, Telangana State, India
| Available Reg Filing : ASMF |
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34164
Submission : 2019-09-30
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Complete
Rev. Date : 2020-11-05
Pay. Date : 2020-09-28
DMF Number : 35201
Submission : 2020-09-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-11-05
Pay. Date : 2020-09-26
DMF Number : 34399
Submission : 2020-02-13
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2020-10-14
Pay. Date : 2020-09-09
DMF Number : 35179
Submission : 2020-09-10
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32225
Submission : 2018-02-07
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33725
Submission : 2019-03-29
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2020-10-15
Pay. Date : 2020-08-12
DMF Number : 34628
Submission : 2020-02-27
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2020-10-15
Pay. Date : 2020-08-27
DMF Number : 35138
Submission : 2020-09-08
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35719
Submission : 2021-03-31
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2020-11-01
Pay. Date : 2020-09-22
DMF Number : 35096
Submission : 2020-09-01
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registration Number : 230MF10101
Registrant's Address : Frankfurter Strasse 250 64293 Darmstadt Germany
Initial Date of Registration : 2018-08-02
Latest Date of Registration : 2018-08-02

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-511n
Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-0511
Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...
Date of Issue : 2025-07-11
Valid Till : 2028-06-25
Written Confirmation Number : WC-0023
Address of the Firm : Sy. No\'s. 52,53,58,59,61 to 78, 127 & 128, Pydibhimavaram Village & Sy. No\'s. ...

Date of Issue : 2022-12-09
Valid Till : 2025-12-03
Written Confirmation Number : WC-0457
Address of the Firm : Sy No 544, 545 & 546, Bhiknoor (V), Bhiknoor (M), Kamareddy-503101, Telangana, I...

Date of Issue : 2025-09-12
Valid Till : 2028-07-02
Written Confirmation Number : WC-0182
Address of the Firm : Unit I, Survey No. 239 & 240, Dothigudem (V), Pochampally (M), Yadadri Bhuvanagi...

Date of Issue : 2025-09-29
Valid Till : 2028-08-04
Written Confirmation Number : WC-0127
Address of the Firm : A1/B, SIPCOT Industrial Complex,\r\nKudikadu, Cuddalore -607005, Tamil Nadu, Ind...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SAFINAMIDE MESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Approval Date : 2025-06-13
Application Number : 215913
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SAFINAMIDE MESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2025-06-13
Application Number : 215913
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : SAFINAMIDE MESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Approval Date : 2023-06-14
Application Number : 215902
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : SAFINAMIDE MESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2023-06-14
Application Number : 215902
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AB
Brand Name : XADAGO
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2017-03-21
Application Number : 207145
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SAFINAMIDE MESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Approval Date : 2024-12-31
Application Number : 215978
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Brand Name : SAFINAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Approval Date :
Application Number : 216020
RX/OTC/DISCN :
RLD :
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SAFINAMIDE MESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Approval Date : 2024-04-25
Application Number : 215739
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SAFINAMIDE MESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2024-04-25
Application Number : 215739
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Brand Name : SAFINAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Approval Date :
Application Number : 215945
RX/OTC/DISCN :
RLD :
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Xadago
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Xadago
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Xadago
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Xadago
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
95
PharmaCompass offers a list of Safinamide Methanesulfonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Safinamide Methanesulfonate manufacturer or Safinamide Methanesulfonate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Safinamide Methanesulfonate manufacturer or Safinamide Methanesulfonate supplier.
PharmaCompass also assists you with knowing the Safinamide Methanesulfonate API Price utilized in the formulation of products. Safinamide Methanesulfonate API Price is not always fixed or binding as the Safinamide Methanesulfonate Price is obtained through a variety of data sources. The Safinamide Methanesulfonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NW 1015 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NW 1015, including repackagers and relabelers. The FDA regulates NW 1015 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NW 1015 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NW 1015 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NW 1015 supplier is an individual or a company that provides NW 1015 active pharmaceutical ingredient (API) or NW 1015 finished formulations upon request. The NW 1015 suppliers may include NW 1015 API manufacturers, exporters, distributors and traders.
click here to find a list of NW 1015 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NW 1015 DMF (Drug Master File) is a document detailing the whole manufacturing process of NW 1015 active pharmaceutical ingredient (API) in detail. Different forms of NW 1015 DMFs exist exist since differing nations have different regulations, such as NW 1015 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NW 1015 DMF submitted to regulatory agencies in the US is known as a USDMF. NW 1015 USDMF includes data on NW 1015's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NW 1015 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NW 1015 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The NW 1015 Drug Master File in Japan (NW 1015 JDMF) empowers NW 1015 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the NW 1015 JDMF during the approval evaluation for pharmaceutical products. At the time of NW 1015 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of NW 1015 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NW 1015 Drug Master File in Korea (NW 1015 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NW 1015. The MFDS reviews the NW 1015 KDMF as part of the drug registration process and uses the information provided in the NW 1015 KDMF to evaluate the safety and efficacy of the drug.
After submitting a NW 1015 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NW 1015 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NW 1015 suppliers with KDMF on PharmaCompass.
A NW 1015 written confirmation (NW 1015 WC) is an official document issued by a regulatory agency to a NW 1015 manufacturer, verifying that the manufacturing facility of a NW 1015 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting NW 1015 APIs or NW 1015 finished pharmaceutical products to another nation, regulatory agencies frequently require a NW 1015 WC (written confirmation) as part of the regulatory process.
click here to find a list of NW 1015 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NW 1015 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NW 1015 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NW 1015 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NW 1015 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NW 1015 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NW 1015 suppliers with NDC on PharmaCompass.
NW 1015 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NW 1015 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NW 1015 GMP manufacturer or NW 1015 GMP API supplier for your needs.
A NW 1015 CoA (Certificate of Analysis) is a formal document that attests to NW 1015's compliance with NW 1015 specifications and serves as a tool for batch-level quality control.
NW 1015 CoA mostly includes findings from lab analyses of a specific batch. For each NW 1015 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NW 1015 may be tested according to a variety of international standards, such as European Pharmacopoeia (NW 1015 EP), NW 1015 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NW 1015 USP).